Saudi Arabia Multi Cancer Early Detection Market Size & Outlook
The multi cancer early detection market in Saudi Arabia is expected to reach a projected revenue of US$ 14.5 million by 2030. A compound annual growth rate of 12.1% is expected of Saudi Arabia multi cancer early detection market from 2025 to 2030.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI ↗
Saudi Arabia multi cancer early detection market highlights
The Saudi Arabia multi cancer early detection market generated a revenue of USD 7.3 million in 2024 and is expected to reach USD 14.5 million by 2030.
The Saudi Arabia market is expected to grow at a CAGR of 12.1% from 2025 to 2030.
In terms of segment, gene panel, ldt & others was the largest revenue generating type in 2024.
Liquid Biopsy is the most lucrative type segment registering the fastest growth during the forecast period.
Multi cancer early detection market data book summary
Market revenue in 2024
USD 7.3 million
Market revenue in 2030
USD 14.5 million
Growth rate
12.1% (CAGR from 2025 to 2030)
Largest segment
Gene panel, ldt & others
Fastest growing segment
Liquid Biopsy
Historical data
2018 - 2023
Base year
2024
Forecast period
2025 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Liquid Biopsy, Gene Panel, LDT & Others
Key market players worldwide
Illumina Inc, Exact Sciences Corp, Foundation Medicine, Guardant Health Inc, Burning Rock Biotech Ltd ADR, Freenome, AnchorDx, GeneCast, Elypta
Other key industry trends
In terms of revenue, Saudi Arabia accounted for 0.7% of the global multi cancer early detection market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Middle East & Africa, Saudi Arabia multi cancer early detection market is projected to lead the regional market in terms of revenue in 2030.
South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 10.5 million by 2030.
Some of the key market participants in the Saudi Arabia MCED market are Imagia Canexia Health, Anwa Medical Company, and Sysmex Corporation. The growth of this market can primarily be attributed to increasing involvement of the government and rising awareness about the benefits of noninvasive diagnostic procedures.
In addition, the rapid advancements in NGS and PCR technologies have improved the accuracy of liquid biopsies over the years. Moreover, local as well as international market players are focusing on expanding their networks in Saudi Arabia, as awareness and adoption of NGS technologies are increasing in the country.
For instance, in May 2021, Euformatics signed a strategic distribution partnership with Al Jeel to extend the reach of its NGS software products in the country. In addition, research institutes, such as King Abdullah University of Science and Technology (KAIMRC), are providing a conducive research environment with modern technologies to enhance the NGS platform.
Saudi Arabia Multi Cancer Early Detection Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Multi Cancer Early Detection Market Outlook will help companies and investors design strategic landscapes.
Gene Panel, Ldt & Others was the largest segment with a revenue share of 104.11% in 2024.
Horizon Databook has segmented the Saudi Arabia multi cancer early detection market based on liquid biopsy, gene panel, ldt & others covering the revenue growth of each sub-segment from 2018 to 2030.
Some of the key market participants in the Saudi Arabia MCED market are Imagia Canexia Health, Anwa Medical Company, and Sysmex Corporation. The growth of this market can primarily be attributed to increasing involvement of the government and rising awareness about the benefits of noninvasive diagnostic procedures.
In addition, the rapid advancements in NGS and PCR technologies have improved the accuracy of liquid biopsies over the years. Moreover, local as well as international market players are focusing on expanding their networks in Saudi Arabia, as awareness and adoption of NGS technologies are increasing in the country.
For instance, in May 2021, Euformatics signed a strategic distribution partnership with Al Jeel to extend the reach of its NGS software products in the country. In addition, research institutes, such as King Abdullah University of Science and Technology (KAIMRC), are providing a conducive research environment with modern technologies to enhance the NGS platform.
Saudi Arabia Multi Cancer Early Detection Market Type Outlook (Revenue, USD Million , 2018-2030)
Liquid Biopsy
Gene Panel, LDT & Others
Saudi Arabia Multi Cancer Early Detection Market End Use Outlook (Revenue, USD Million , 2018-2030)
Hospitals
Diagnostic Laboratories
Others
Reasons to subscribe to Multi Cancer Early Detection Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Multi Cancer Early Detection Market Outlook databook
Our clientele includes a mix of Multi Cancer Early Detection Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Multi Cancer Early Detection Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Multi Cancer Early Detection Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Saudi Arabia Multi Cancer Early Detection Market, 2018-2030 (US$M)